𝐏𝐨𝐥𝐥 𝐜𝐥𝐨𝐬𝐞𝐝 - 52% of respondents associated ALIF/LLIF with lower rates of repoerative ASD - but, the latest research shows, it’s not so clear cut.
In last week’s poll, we asked:
"Which interbody fusion technique do you associate with lower rates of reoperative ASD when treating degenerative disc disease?"
In a large-scale study, “𝐴𝑟𝑒 𝑡ℎ𝑒𝑟𝑒 𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒𝑠 𝑖𝑛 𝑡ℎ𝑒 𝑟𝑒𝑜𝑝𝑒𝑟𝑎𝑡𝑖𝑜𝑛 𝑟𝑎𝑡𝑒𝑠 𝑓𝑜𝑟 𝑜𝑝𝑒𝑟𝑎𝑡𝑖𝑣𝑒 𝑎𝑑𝑗𝑎𝑐𝑒𝑛𝑡-𝑠𝑒𝑔𝑚𝑒𝑛𝑡 𝑑𝑖𝑠𝑒𝑎𝑠𝑒 𝑏𝑒𝑡𝑤𝑒𝑒𝑛 𝐴𝐿𝐼𝐹+𝑃𝑆, 𝑃𝐿𝐼𝐹+𝑃𝑆, 𝑇𝐿𝐼𝐹+𝑃𝑆, 𝑎𝑛𝑑 𝐿𝐿𝐼𝐹+𝑃𝑆?” (JNS Spine, 40:733–740, 2024), Bains et al. found no statistically significant difference between the groups.
Access the study here: https://lnkd.in/dmzcPvai
While ALIF has been said to facilitate the restoration of segmental lumbar lordosis, disc height, and alignment, and potentially reduce the risk of ASD, this study - including more than 5,000 patients with a long follow up - could NOT confirm this.
The origins, risk factors, and impact of interbody techniques on the reoperation rates for ASD in lumbar fusion remain elusive.
This study, and others like it, challenge our assumed knowledge and show that science should lead our understanding of best practice in spine fusion surgery.
At Neo, science leads every stage in our platform development process – leveraging the latest in material science and understanding to deliver the most advanced thoracolumbar fusion platform available on the market today.
Visit us at neo-medical.com and find out how, together, we’re taking the next step in thoracolumbar fusion surgery!
#LedByScience
#NextGenTech
#SpineSurgery
#ThoracolumbarFusion
